Childhood pemphigus vulgaris treated with dapsone: A case report

被引:14
作者
Bjarnason, B
Skoglund, C
Flosadottir, E
机构
[1] Karolinska Hosp, Dept Dermatol, S-10401 Stockholm, Sweden
[2] Karolinska Hosp, Dept Clin Immunol, S-10401 Stockholm, Sweden
[3] Karolinska Inst, Fac Odontol, Dept Pediat Dent, Stockholm, Sweden
关键词
D O I
10.1046/j.1525-1470.1998.1998015381.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A 5-year-old boy developed hemorrhagic mucocutaneous blisters on various parts of the body leading to fetor, dysphagia, dysuria, anal pruritus, pain on defecation, and weight loss, The histopathology showed the classic features of pemphigus vulgaris, and direct immunofluorescence showed intercellular deposition of IgG and C3 in the epidermis, Circulating pemphigus antibodies were also detected, He was treated with a combination of systemic prednisone and dapsone which induced a rapid remission and controlled the disease well. He has been in remission for 1 year and 7 months with no immunosuppressive therapy except for the use of topical agents for the oral lesions. An adjuvant to corticosteroids has been used only once before in children with pemphigus vulgaris under the age of 12 years, This is the third and the youngest child in the literature treated in this fashion.
引用
收藏
页码:381 / 383
页数:3
相关论文
共 9 条
[1]   JUVENILE PEMPHIGUS [J].
AHMED, AR ;
SALM, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 8 (06) :799-807
[2]  
Beutner EH, 1987, IMMUNOPATHOLOGY SKIN, V3rd
[3]   DAPSONE - MODES OF ACTION, TOXICITY AND POSSIBLE STRATEGIES FOR INCREASING PATIENT TOLERANCE [J].
COLEMAN, MD .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (05) :507-513
[4]  
FLEMING CM, 1992, MOL PHARMACOL, V41, P975
[5]   PEMPHIGUS IN CHILDREN [J].
KANWAR, AJ ;
KAUR, S .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (05) :343-346
[6]   MECHANISM OF INHIBITION OF MYELOPEROXIDASE BY ANTIINFLAMMATORY DRUGS [J].
KETTLE, AJ ;
WINTERBOURN, CC .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (10) :1485-1492
[7]  
UETRECHT J, 1988, J PHARMACOL EXP THER, V245, P274
[8]   MECHANISMS BY WHICH CLOFAZIMINE AND DAPSONE INHIBIT THE MYELOPEROXIDASE SYSTEM - A POSSIBLE CORRELATION WITH THEIR ANTIINFLAMMATORY PROPERTIES [J].
VANZYL, JM ;
BASSON, K ;
KRIEGLER, A ;
VANDERWALT, BJ .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (03) :599-608
[9]   INHIBITION OF NEUTROPHIL ADHERENCE TO ANTIBODY BY DAPSONE - A POSSIBLE THERAPEUTIC MECHANISM OF DAPSONE IN THE TREATMENT OF IGA DERMATOSES [J].
VU, TN ;
KADUNCE, DP ;
HENDRIX, JD ;
GAMMON, WR ;
ZONE, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) :349-355